14 April 2021 - Approval based on Phase 3 CheckMate-9ER trial results showing Opdivo in combination with Cabometyx significantly improved overall ...
15 April 2021 - Consultation on the content of the draft Cost Recovery Implementation Statement for listing medicines on the ...
14 April 2021 - Parents of paediatric patients with haemophilia A are demanding the regulator to change the criteria for ...
14 April 2021 - Moleculin Biotech announced today that the U.S. FDA has granted rare paediatric disease designation to its ...
14 April 2021 - The TGA has granted a provisional determination to GSK in relation to the monoclonal antibody treatment, ...
14 April 2021 - Approval based on unprecedented results from the ADAURA Phase III trial where Tagrisso reduced the risk ...
14 April 2021 - PHARMAC is making it easier for clinicians to access six treatments for rare metabolic disorders for ...
13 April 2021 - Atossa Therapeutics today announced that an ovarian cancer patient has begun treatment with Atossa’s proprietary oral endoxifen. ...
13 April 2021 - ISPOR announced today the publication of new guidance on how to evaluate the quality and risk ...
13 April 2021 - A disparity in UK access to a medicine for Duchenne muscular dystrophy has been addressed, after ...
13 April 2021 - Qilian International today announced that 16 of its products have been included in the latest version of ...
13 April 2021 - For countries in Europe, negotiating a deal with a pharma company over drug prices is the ...
13 April 2021 - The Scottish Medicines Consortium has approved NHS funding for four new medicines, including treatments for multiple ...
13 April 2021 - Today the Food and Drug Administration granted accelerated approval to sacituzumab govitecan (Trodelvy, Immunomedics) for patients ...
13 April 2021 - Designation offers potential for expedited development pathway and reinforces TTP399’s potential to provide a substantial clinical benefit. ...